Daymark Wealth Partners LLC Sells 110,652 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Daymark Wealth Partners LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 95.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,601 shares of the healthcare conglomerate's stock after selling 110,652 shares during the period. Daymark Wealth Partners LLC's holdings in UnitedHealth Group were worth $2,934,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UNH traded up $6.23 during trading on Friday, hitting $308.85. The company's stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,404,577. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm has a market cap of $280.17 billion, a PE ratio of 12.93, a P/E/G ratio of 1.46 and a beta of 0.45. The business's 50 day simple moving average is $336.21 and its 200-day simple moving average is $453.53.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the business earned $6.91 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Analyst Ratings Changes

Several research firms have issued reports on UNH. Wolfe Research cut their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Truist Financial reaffirmed a "buy" rating and set a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. HSBC reaffirmed a "reduce" rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Finally, TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $415.57.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John H. Noseworthy purchased 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares in the company, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 in the last three months. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.